on the afternoon of may 1, nurses got clearances from doctors and wheeled robert into helen's room....
thank you!
...
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
yesterday they welcomed the findings of coroner patrick mcgurgan, who criticised the staff caring for mrs cavanagh over a series of missed opportunities..